Innovus Pharmaceuticals Reports Record Quarterly Revenue for the First Quarter 2018 of $4.5 million, Beating Previous Estimate and Net Loss Decrease of 28% Compared to the Same Quarterly Period in 201

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Innovus Pharmaceuticals Reports Record Quarterly Revenue for the First Quarter 2018 of $4.5 million, Beating Previous Estimate and Net Loss Decrease of 28% Compared to the Same Quarterly Period in 201

Innovus Pharma (INNV) Reports Q1 Loss of $0.01

May 14, 2018 4:18 PM EDT

Innovus Pharma (: INNV) reported Q1 EPS of ($0.01). Revenue for the quarter came in at $4.54 million.

We are delighted with our first quarter net revenues of $4.5 million, which beat our previously announced first quarter expectations, stated Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. We are very confident in our business strategy and in our ability to grow our sales revenue through our continuously expanding and proprietary Beyond Human sales and marketing channels and to develop new products that satisfy the needs of our growing... More